Achillion Pharmaceuticals Inc. (ACHN) was one of the Russell 2000's biggest losers for September 5 as the stock slid 7.94% to $12.17, a loss of $1.05 per share. Starting at an opening price of $13.06 a share, the stock traded between $11.33 and $13.09 over the course of the trading day. Volume was 19,248,817 shares over 51,379 trades, against an average daily volume of 0 shares and a total float of 97,788,046.
The losses send Achillion Pharmaceuticals Inc. down to a market cap of $1,190,080,520. In the last year, Achillion Pharmaceuticals Inc. has traded between $0.00 and $0.00, and its 50-day SMA is currently $0.00.
For a full analysis of Achillion Pharmaceuticals Inc., check out Equities.com's E.V.A. report.
Achillion Pharmaceuticals Inc., has employees and is headquartered in .
One of the most effective tools for tracking the market for small-cap stocks is the Russell 2000, the nation's leading small-cap index created by industry stalwart Russell Investments. Unlike the well-known Dow Jones Industrial Average (DJIA) and S&P 500, Russell's indices eschew committee selection in favor of a more objective, rules-based system for selecting index membership.
The broad-based Russell 3000, which is meant to cover the stock market as a whole, is simply the 3,000 companies with the largest market cap in the United States. The Russell 2000 is then just the bottom 2,000 companies of that index, offering a look at those small-cap companies with smaller market caps. It makes for an unbiased overview of the small-cap stocks that can help any investor get a better sense of what the market is doing and where it might be headed.
For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.